Thompson D A, Kriss A, Taylor D, Russell-Eggitt I, Hodgkins P, Morgan G, Vellodi A, Gerritsen E J
Ophthalmology Department, Great Ormond Street Hospital for Children, London.
Neuropediatrics. 1998 Jun;29(3):137-44. doi: 10.1055/s-2007-973550.
Autosomal recessive (AR) osteopetrosis has a rapid course and manifests in the first months of life. Visual loss occurs because of optic nerve compromise, and more rarely retinal dysfunction (which may be a part of a primary neurodegeneration). The only curative treatment currently available is bone marrow transplantation (BMT). It has been suggested that BMT is contraindicated if AR osteopetrosis is associated with a primary neurodegeneration. Visual impairment tends to be irreversible after BMT. The young age of the patients makes reliable, objective tests of visual function especially important. We have reviewed the flash electroretinograms (ERGs) and flash and pattern visual evoked potentials (VEPs) recorded without sedation from 15 patients with AR osteopetrosis, 11 of whom were recorded longitudinally. The most frequent, early indication of visual dysfunction was a delay in the pattern or flash VEP latency. This first affects the pattern reversal VEP to small checks. Importantly this often preceded fundal changes of optic disc pallor, and evidence of optic nerve compression on neuroimaging. Only two patients had ERG evidence of retinal dysfunction affecting both rods and cones. One of these patients had a distinctive fundal appearance, but did not have evidence of associated neuronal degenerative disease. The other patient was lost to follow-up. In the patients reviewed in this study successful BMT and optic nerve decompression did not result in VEP improvement. Fundoscopy, VEP and ERG testing are indicated when the diagnosis of AR osteopetrosis is suspected and provide a useful means of monitoring visual involvement.
常染色体隐性(AR)骨硬化症病程进展迅速,在出生后的头几个月就会出现症状。视力丧失是由于视神经受压所致,视网膜功能障碍则较为少见(可能是原发性神经退行性变的一部分)。目前唯一的治愈性治疗方法是骨髓移植(BMT)。有人提出,如果AR骨硬化症与原发性神经退行性变相关,则禁忌进行BMT。骨髓移植后视力损害往往不可逆转。患者年龄较小,因此可靠、客观的视觉功能测试尤为重要。我们回顾了15例AR骨硬化症患者在未使用镇静剂的情况下记录的闪光视网膜电图(ERG)以及闪光和图形视觉诱发电位(VEP),其中11例进行了纵向记录。视觉功能障碍最常见的早期表现是图形或闪光VEP潜伏期延迟。这首先影响到对小方格的图形翻转VEP。重要的是,这种情况往往先于视盘苍白的眼底改变以及神经影像学上视神经受压的证据出现。只有两名患者有视网膜功能障碍的ERG证据,累及视杆细胞和视锥细胞。其中一名患者眼底外观独特,但没有相关神经元退行性疾病的证据。另一名患者失访。在本研究中接受评估的患者中,成功的骨髓移植和视神经减压并未使VEP得到改善。当怀疑患有AR骨硬化症时,应进行眼底检查、VEP和ERG测试,这些检查是监测视力受累情况的有用手段。